MedTrace Logo

Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism

NCT01817894 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2013-12-02

No results posted yet for this study

Summary

Split-face investigation of the efficacy of applying Eflornithin cream twice daily for six months after a period with six laser treatments for hair removal.

Conditions

  • Hirsutism

Interventions

DRUG

Eflornithine cream 11.5 w/w %

Split face intervention with application of Eflornithine cream 11.5 w/w % versus no treatment for six months

Sponsors & Collaborators

  • Bispebjerg Hospital

    lead OTHER

Principal Investigators

  • Elisabeth H Taudorf, MD · BispbejergH

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • Denmark

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01817894 on ClinicalTrials.gov